Hinge Health, Inc.

NYSE:HNGE

Medical - Healthcare Information Services

Healthcare
$114.53 -0.36%

-$0.24 today

Market cap
$9.31B
Beta
1.99
P/E (TTM)
-10.3
EPS (TTM)
-$6.49
52W Low $30.08High $70.72

Volume 1.23M

Average 1.34M

HNGE Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Hinge Health, Inc.NYSE: HNGE

Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026

Cash & equivalents rises 20.7% from a year ago

Cash & equivalents stood at $286.22M at the end of Q2 FY2026, up 20.7% from a year earlier and up 52.2% from the prior quarter.

Context

  • Cash & equivalents amounted to 34.6% of total assets at the end of Q2 FY2026, up 0.4 pp from a year earlier.
  • Cash & equivalents increased in 1 of the last 2 fiscal years.
  • FY2025 was the lowest annual figure in the 3 fiscal years shown.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +20.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$286.22M+52.2% QoQ
Last fiscal yearDec 2025
$208M-30.8% YoY
Year agoJun 2025
$237.17M+20.7% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+20.7%——
1 year-30.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
208M USD
Year-over-year change
-30.8%
2-year CAGR
-5.9%

Cash & Equivalents vs competitors

How HNGE compares with its peers on the latest reported figures

  • HNGE's Jun 2026 cash & equivalents of $286.22M is the 2nd highest of the 5 companies compared; the peer median is $122.45M.
  • Its year-over-year change of +20.7% is the 2nd highest of 5, against a peer median of -11.9%.
  • Cash & equivalents amounts to 34.6% of total assets for HNGE, versus a peer median of 3.8%.
HNGE Competitors Peer median
Cash & Equivalents for HNGE and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SNNSmith & Nephew plcDec 2025$557M -10.0%+16.8%5.3%
HNGEHinge Health, Inc.Jun 2026$286.22M +20.7%—34.6%
OMDAOmada HealthMar 2026$211.77M +256.5%+9.7%69.9%
ENOVEnovis CorporationApr 2026$33.13M -13.9%+14.4%0.9%
USPHU.S. Physical Therapy, Inc.Mar 2026$28.44M -27.4%+4.0%2.3%
Peer median (excluding HNGE) $122.45M-11.9%+12.1%3.8%

Competitors are the stored peer set for HNGE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents234.95M300.79M208M
Short-term Investments188.4M165.79M155.87M
Net Receivables46.56M42.5M66.06M
Inventory13.29M10.87M15.64M
Other Current Assets32.31M39.59M57.41M
Total Current Assets529.88M583.45M533.9M
Property, Plant & Equipment (Net)22.48M16.99M17.35M
Goodwill61.61M61.61M64.1M
Intangible Assets2.19M1.81M2.51M
Long-term Investments00113.17M
Tax Assets000
Other Non-current Assets6.38M9.41M13.73M
Total Non-current Assets92.65M89.81M210.86M
Total Assets622.53M673.26M744.76M
Account Payables000
Short-term Debt000
Tax Payables8.2M2.12M0
Deferred Revenue140.47M217.63M300.86M
Other Current Liabilities6.37M4.16M11.46M
Total Current Liabilities184.16M249.3M362.41M
Long-term Debt000
Deferred Tax Liabilities000
Deferred Revenue (Non-current)000
Other Non-current Liabilities000
Total Non-current Liabilities11.1M7.26M3.82M
Total Liabilities195.25M256.56M366.23M
Common Stock000
Retained Earnings(510.8M)(522.74M)(1.05B)
Accumulated OCI60K68K(20K)
Other Stockholders Equity000
Minority Interest000
Total Equity427.28M416.7M378.54M
Total Debt15.73M11.07M8.04M
Net Debt(219.22M)(289.71M)(199.96M)

Hinge Health, Inc.

NYSE:HNGE

Intrinsic Alpha fair value

Locked

Current Price

$114.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.